Hogan Daniel R, Salomon Joshua A
Harvard Center for Population and Development Studies, Harvard School of Public Health, 9 Bow Street, Cambridge, MA 02138, USA.
Bull World Health Organ. 2005 Feb;83(2):135-43. Epub 2005 Feb 24.
Strategies for confronting the epidemic of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) have included a range of different approaches that focus on prevention and treatment. However, debate persists over what levels of emphasis are appropriate for the different components of the global response. This paper presents an overview of this debate and briefly summarizes the evidence on a range of interventions designed to prevent the spread of HIV infection, paying particular attention to voluntary counselling and testing, treatment for sexually transmitted infections and prevention of mother-to-child transmission. We also review the experience with antiretroviral therapy to date in terms of response rates and survival rates, adherence, drug resistance, behavioural change and epidemiological impact. Although various studies have identified strategies with proven effectiveness in reducing the risks of HIV infection and AIDS mortality, considerable uncertainties remain. Successful integration of treatment and prevention of HIV/AIDS will require a balanced approach and rigorous monitoring of the impact of programmes in terms of both individual and population outcomes.
应对人类免疫缺陷病毒/获得性免疫缺陷综合征(HIV/AIDS,艾滋病)流行的策略包括一系列侧重于预防和治疗的不同方法。然而,对于全球应对措施的不同组成部分应给予何种程度的重视,仍存在争议。本文概述了这一争议,并简要总结了一系列旨在预防HIV感染传播的干预措施的证据,特别关注自愿咨询和检测、性传播感染的治疗以及母婴传播的预防。我们还根据应答率和生存率、依从性、耐药性、行为改变以及流行病学影响,回顾了迄今为止抗逆转录病毒疗法的经验。尽管各种研究已经确定了在降低HIV感染风险和艾滋病死亡率方面具有 proven effectiveness(原文如此,可能有误,推测应为“已证实有效性”)的策略,但仍存在相当多的不确定性。成功整合HIV/AIDS的治疗和预防需要一种平衡的方法,并对项目在个体和人群结果方面的影响进行严格监测。